We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Upstream Completes Acquisition of Genetic Diagnostic Marker Company
News

Upstream Completes Acquisition of Genetic Diagnostic Marker Company

Upstream Completes Acquisition of Genetic Diagnostic Marker Company
News

Upstream Completes Acquisition of Genetic Diagnostic Marker Company

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Upstream Completes Acquisition of Genetic Diagnostic Marker Company"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Upstream Biosciences Inc., formerly Integrated Brand Solutions Inc. has announced the completion of the acquisition of all of the common shares of Upstream Biosciences Inc.

The transaction was completed on March 1, 2006 pursuant to the closing of an Amended and Restated Share Exchange Agreement among the Company, Upstream Canada and the shareholders of Upstream Canada.

The Company acquired all of the 6,000,000 issued and outstanding common shares of Upstream Canada in exchange for the issuance by the Company of 24,000,000 shares of the Company's common stock to the shareholders of Upstream Canada.

As a result of the transaction, Upstream Canada is now a wholly-owned subsidiary of the Company.

As of March 1, 2006, the Company had 44,300,000 shares of common stock issued and outstanding.

The former shareholders of Upstream Canada hold 24,000,000 shares of the Company's common stock, representing approximately 54.2% of the Company's issued and outstanding shares.

As part of the transaction, Joel Bellenson and Dexster Smith were appointed to the Company's board of directors on March 1, 2006.

Additionally, Joel Bellenson was appointed as Chief Executive Officer of the Company and Dexster Smith was appointed as President of the Company.

As of March 1, 2006, Steve Bajic resigned as President of the Company but remains as a director and the Secretary and Treasurer of the Company.

The shares issued in this transaction have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act of 1933, as amended.

Advertisement